465 related articles for article (PubMed ID: 18254815)
1. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
[TBL] [Abstract][Full Text] [Related]
3. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
[TBL] [Abstract][Full Text] [Related]
5. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
[TBL] [Abstract][Full Text] [Related]
6. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.
Sharquie KE; Al-Tikreety MM; Al-Mashhadani SA
Dermatol Surg; 2006 Dec; 32(12):1429-36. PubMed ID: 17199649
[TBL] [Abstract][Full Text] [Related]
7. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
[TBL] [Abstract][Full Text] [Related]
8. Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.
Leenutaphong V; Nettakul A; Rattanasuwon P
J Med Assoc Thai; 1999 Sep; 82(9):868-75. PubMed ID: 10561942
[TBL] [Abstract][Full Text] [Related]
9. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
Kaufman BP; Alexis AF
J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
[TBL] [Abstract][Full Text] [Related]
10. Topical 10% zinc sulfate solution for treatment of melasma.
Sharquie KE; Al-Mashhadani SA; Salman HA
Dermatol Surg; 2008 Oct; 34(10):1346-9. PubMed ID: 18616534
[TBL] [Abstract][Full Text] [Related]
11. Effect of melasma on quality of life in a sample of women living in southern Brazil.
Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
[TBL] [Abstract][Full Text] [Related]
12. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.
Dogramaci AC; Havlucu DY; Inandi T; Balkrishnan R
J Dermatolog Treat; 2009; 20(2):95-9. PubMed ID: 18720186
[TBL] [Abstract][Full Text] [Related]
13. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation.
Grimes PE
Cutis; 2004 Dec; 74(6):362-8. PubMed ID: 15663072
[TBL] [Abstract][Full Text] [Related]
14. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
15. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
Dayal S; Sahu P; Dua R
J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
Jang WS; Lee CK; Kim BJ; Kim MN
Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
18. Salicylic acid for the treatment of melasma: new acquisitions for monitoring the clinical improvement.
Fabbrocini G; De Vita V; Marasca C; Palmisano F; Monfrecola G
Skin Res Technol; 2013 Nov; 19(4):466-73. PubMed ID: 23527534
[TBL] [Abstract][Full Text] [Related]
19. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
Monheit GD; Dreher F
J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
[TBL] [Abstract][Full Text] [Related]
20. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
